V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003917 | 310001647 | 1.77 | 82.6 | Palliative (P) | 2017-05-26 | 2017-05-28 | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE + MESNA + METHOTREXATE | N | N | 310018876 | CAPECITABINE |
| 310003918 | 310001648 | 1.6 | 53.8 | Neo-adjuvant (N) | 2017-12-01 | 2017-12-05 | ECX | N | N | 310018879 | ECX |
| 310003919 | 310001649 | null | 0 | Disease modification (D) | 2015-11-10 | 2015-11-12 | EOX | null | null | 310018882 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003920 | 310001649 | 1.52 | 52.8 | Adjuvant (A) | 2016-04-21 | 2016-04-21 | CHOEP - 21 days | N | N | 310018882 | CHOEP |
| 310003921 | 310009123 | 1.83 | 13.2 | Curative (C) | 2017-07-03 | 2017-07-04 | null | N | Y | 310018887 | NOT MATCHED |
| 310003922 | 310010375 | 1.82 | 83 | Palliative (P) | 2016-09-19 | 2016-09-23 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018888 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003923 | 310011063 | null | 74 | Palliative (P) | 2016-02-19 | 2016-03-11 | Rituximab | 2 | N | 310018889 | RITUXIMAB |
| 310003924 | 310001650 | 0 | 95 | Palliative (P) | 2014-02-18 | 2014-02-21 | Liposomal Doxorubicin (Caelyx) | N | N | 310018893 | EOX |
| 310003925 | 310001650 | 1.54 | 76 | Palliative (P) | 2016-01-17 | 2016-01-17 | Bexarotene | Y | N | 310018893 | CAPECITABINE + OXALIPLATIN |
| 310003926 | 310001651 | 1.55 | 68 | Palliative (P) | 2017-06-11 | 2017-06-30 | Rituximab | N | N | 310018895 | CAPECITABINE + CISPLATIN |
| 310003927 | 310001652 | 0 | 0 | Palliative (P) | 2015-04-08 | 2015-04-27 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018896 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003928 | 310001653 | 1.57 | null | Curative (C) | 2014-09-27 | 2014-10-04 | NB Low/Interm risk guidelines Carbo/Etop | N | null | 310018898 | NOT MATCHED |
| 310003929 | 310001654 | null | 108 | Curative (C) | 2013-08-19 | 2013-09-02 | CISPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | 2 | N | 310018899 | NOT MATCHED |
| 310003930 | 310001655 | null | 58 | null | null | 2016-01-12 | IPILIMUMAB + NIVOLUMAB | N | N | 310018900 | IMATINIB |
| 310003931 | 310001656 | 0 | 98 | Curative (C) | 2014-07-20 | 2014-08-27 | Hydroxycarbamide | N | N | 310018902 | IMATINIB |
| 310003932 | 310001657 | 1.53 | 78.2 | Palliative (P) | 2013-12-02 | 2013-12-03 | IPILIMUMAB + NIVOLUMAB | 2 | N | 310018904 | IPILIMUMAB + NIVOLUMAB |
| 310003933 | 310006726 | 1.6 | 59 | Disease modification (D) | 2017-03-19 | 2017-03-19 | Bexarotene | N | null | 310018905 | IMATINIB |
| 310003934 | 310009124 | 1.79 | 0 | Palliative (P) | 2017-12-22 | 2017-12-23 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018907 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003937 | 310001659 | 1.63 | 86.35 | Palliative (P) | 2014-03-26 | 2014-04-04 | CISPLATIN + FLUOROURACIL | null | null | 310018919 | BCG |
| 310003938 | 310001659 | 1.65 | 53 | Disease modification (D) | 2018-06-20 | 2018-06-21 | Vemurafenib | N | N | 310018919 | RITUXIMAB |
| 310003939 | 310001659 | 1.57 | 53.4 | null | 2017-10-06 | 2017-11-03 | IPILIMUMAB + NIVOLUMAB | null | Y | 310018919 | OXALIPLATIN + MDG |
| 310003940 | 310001659 | 1.63 | 69.7 | Palliative (P) | null | 2016-02-16 | IPILIMUMAB + NIVOLUMAB | 2 | N | 310018919 | IPILIMUMAB + NIVOLUMAB |
| 310003942 | 310006729 | 1.69 | 47.5 | Palliative (P) | 2018-08-31 | 2018-09-01 | LIPOSOMAL DOXORUBICIN | N | null | 310018928 | VEMURAFENIB |
| 310003943 | 310006729 | 1.51 | 54.2 | Adjuvant (A) | 2015-12-09 | 2015-12-09 | IPILIMUMAB + NIVOLUMAB | 02 | N | 310018928 | CISPLATIN + ETOPOSIDE |
| 310003944 | 310006729 | 1.73 | 97 | Neo-adjuvant (N) | 2017-05-09 | 2017-05-28 | CISPLATIN + FLUOROURACIL | N | N | 310018928 | EOX |
| 310003945 | 310006729 | 1.73 | 97.6 | Curative (C) | 2014-11-28 | 2014-11-28 | null | N | N | 310018928 | NOT MATCHED |
| 310003946 | 310006729 | 1.73 | 53.9 | Palliative (P) | 2016-12-19 | 2016-12-25 | Rituximab | N | N | 310018928 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003947 | 310001661 | 1.64 | 67.7 | Palliative (P) | 2016-08-07 | 2016-08-21 | Rituximab | N | N | 310018936 | EOX |
| 310003948 | 310006730 | null | null | Palliative (P) | 2014-01-22 | 2014-01-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310018937 | IMATINIB |
| 310003949 | 310001662 | 1.72 | 79.8 | Neo-adjuvant (N) | 2016-11-16 | 2016-12-01 | Capecitabine + Cisplatin | 02 | N | 310018941 | BEXAROTENE |
| 310003950 | 310001663 | 1.62 | 93.5 | Adjuvant (A) | 2014-02-26 | 2014-03-04 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310018942 | GEMCITABINE |
| 310003951 | 310001664 | 1.75 | null | Curative (C) | null | 2015-02-20 | CHOEP - 21 days | 1 | N | 310018944 | CHOEP |
| 310003952 | 310001665 | null | null | Palliative (P) | 2017-12-06 | 2017-12-13 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 310018945 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003953 | 310001666 | null | 68.7 | Palliative (P) | 2014-05-31 | 2014-06-18 | BEVACIZUMAB + CARBO + PACLITAXEL | Y | N | 310018946 | PACLITAXEL |
| 310003954 | 310006731 | 1.64 | 76.1 | Palliative (P) | null | 2015-05-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | 310018950 | DACARBAZINE |
| 310003957 | 310001668 | null | 63 | Palliative (P) | 2017-06-21 | 2017-06-21 | ECX | N | N | 310018955 | ECX |
| 310003958 | 310001669 | null | null | Palliative (P) | 2016-04-25 | 2016-04-30 | EOX | N | N | 310018957 | HYDROXYCARBAMIDE |
| 310003959 | 310001670 | 1.66 | 100 | Disease modification (D) | 2013-03-25 | 2013-04-04 | ICON8 TRIAL | N | N | 310018959 | IMATINIB |
| 310003960 | 310001671 | null | null | Palliative (P) | 2016-06-28 | 2016-07-05 | GEMCITABINE | 2 | N | 310018960 | GEMCITABINE |
| 310003961 | 310006733 | null | 85.5 | Curative (C) | 2016-02-02 | 2019-03-18 | ICON8 TRIAL | 02 | N | 310018961 | RITUXIMAB |
| 310003962 | 310001672 | 1.63 | null | Disease modification (D) | 2016-11-08 | 2016-11-10 | IMATINIB | 01 | N | 310018963 | BEXAROTENE |
| 310003963 | 310001672 | 1.81 | 80 | Adjuvant (A) | 2013-03-03 | 2013-03-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 310018963 | MITOMYCIN INTRAVESICULAR |
| 310003964 | 310001672 | null | 0 | Palliative (P) | 2015-06-04 | 2015-06-04 | EOX | N | N | 310018963 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003965 | 310001673 | 1.58 | 127.9 | Palliative (P) | 2014-08-31 | 2014-09-15 | Liposomal Doxorubicin (Caelyx) | N | N | 310018968 | OXALIPLATIN + MDG |
| 310003966 | 310001674 | 1.33 | null | Palliative (P) | null | 2014-03-26 | CHOEP - 21 days | N | N | 310018969 | BCG |
| 310003967 | 310001674 | null | 62 | Neo-adjuvant (N) | 2014-05-08 | 2014-05-23 | GEM-P | N | null | 310018969 | CAPECITABINE + OXALIPLATIN |
| 310003968 | 310001675 | 1.71 | 10.1 | Palliative (P) | 2015-10-11 | 2015-10-14 | CYCLOPHOSPHAMIDE + DOXORUBICIN + EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 02 | N | 310018971 | NOT MATCHED |
| 310003969 | 310001675 | null | 64.4 | Curative (C) | 2015-10-30 | 2015-10-30 | CAPECITABINE + OXALIPLATIN | 02 | N | 310018971 | CAPECITABINE + OXALIPLATIN |
| 310003970 | 310001676 | 1.69 | 10.1 | Curative (C) | 2015-04-12 | 2015-05-16 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 310018976 | PACLITAXEL |
| 310003971 | 310001676 | null | null | Palliative (P) | 2016-09-03 | 2016-09-03 | GEMCITABINE | N | N | 310018976 | GEMCITABINE |